CME Information | eqipp.aap.org

Hypertension - Identification and Management

ACCME Accreditation Statement

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this enduring material for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAP designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is accredited for 27.50 NAPNAP CE contact hours of which 1.0 contain pharmacology (Rx), (0 related to psychopharmacology) (0 related to controlled substances), content per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.

The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 27.50 hours of Category 1 credit for completing this program.

This activity is acceptable for a maximum of 27.50 credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

Course Goals

The goal of this EQIPP: Hypertension - Identification and Management course is to help you create plans for improvement and to address gaps identified in key activities of pediatric hypertension care. These activities focus on improving ongoing medical care and patient self-management education and support.

You will collect baseline and follow-up data as you work to improve care and processes through Plan, Do, Study, and Act (PDSA) cycles.

Learning Objectives

By the end of this course, you will:

Be familiar with the following:

The guidelines for pediatric hypertension identification and recommended actions for managing this condition in patients.
The policies that outline the responsibilities for care coordination between the pediatric medical home, the hypertension care team, and other providers.

Recognize how these key activities contribute to high-quality, ongoing hypertension care and implement ideas for change to improve your delivery of care to patients in your practice

Document the measurement of blood pressure for children over 3 years old in all visits.
Interpret the blood pressure measurement based on gender, age, and height percentile.
Confirm the diagnosis of hypertension.
Evaluate for identifiable causes and co-morbidity associated with hypertension.
Discuss lifestyle modifications.
Develop a treatment plan.

Measure and improve hypertension care delivery and processes for the above key activities by doing the following:

Collect and analyze baseline data to establish a starting point for improvement.

Identify one or more performance gaps in one or more key activities of hypertension care.
Create an improvement plan for closing identified performance gap(s) by clarifying the improvement idea to be tested:

AIM: What are we trying to improve or accomplish?
MEASURES: How will we know that a change made is an improvement?
CHANGES: What changes can we make that will result in improvement?

Test your ideas quickly on a small scale so you can determine if the changes lead to improvement.
Collect and analyze follow-up data to measure the results of your test.
Determine how to sustain successful changes to systematically integrate them into the culture, processes, and workflow of your practice.

Create additional improvement plans and repeat PDSA cycles until you reach the maximum potential of providing optimal hypertension care in your practice.

Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

The AAP CME program aims to develop, maintain, and improve the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME program strives to meet participants' educational needs and support their life-long learning with a goal of improving care for children and families. (AAP CME Program Mission Statement, January 2013)

The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP sponsored or jointly sponsored Continuing Medical Education (CME) activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content.

All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity (ACCME Standard 1.1).

The purpose of this policy and its associated procedures is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good.

The content of this CME activity does not necessarily reflect the views or policies of the AAP.

Disclosure of Financial Relationships

All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. *Commercial interest is defined as any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.

Name	Relevant Financial Relationship (Please indicate Yes, or No)	Name of Commercial Interest(s)* Please list name(s) of entity) AND Nature of Relevant Financial Relationship(s)	Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical.
Carissa Baker-Smith, MD, MS, MPH, FAAP (Faculty)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Donald Batisky, MD, FAAP (Faculty)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Daniel Feig, MD, PhD, MS, FAAP (Faculty)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Joseph Flynn, MD, MS, FAAP (Faculty)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
David Kershaw, MD, FCP (SA) (Faculty)	Yes	Medtronic (Stocks/Bonds) sold August 2013 Disclosure reviewed by Robert Perelman, MD on 8/20/2013 No Conflict of Interest Found	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Kevin E. C. Meyers, MD, FAAP (Faculty)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Suzanne Lazorick, MD, MPH, FAAP (Faculty)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Lori Morawski, MPH, CHES (Staff)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Tamiko O’Brill, MS (Staff)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Lynne Colegrove, MBA (Staff)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Suzanne Kirkwood (Staff)	Yes	1. Stock/Bonds relationship with Merck 2. Stocks/Bonds relationship with Sanofi 3. Stocks/Bonds relationship with Amgen Disclosure reviewed by Robert Perelman, MD on 8/20/2013 This staff person's role in the education activity is minimal relative to content and inclusion decisions. As such the disclosure items are not significant. No Conflict of Interest found	I do not intend to discuss an unapproved/investigative use of a commercial product/device.
Becky Harris, CPT, CPLP (Instructional Designer)	No	None	I do not intend to discuss an unapproved/investigative use of a commercial product/device.

Commercial Supporters

This course has been developed by the American Academy of Pediatrics (AAP) with support from the AAP Friends of Children Fund. The work was developed in collaboration with American Society of Pediatric Nephrology (ASPN) and International Pediatric Hypertension Association (IPHA).

Product-Specific Advertising

No product-specific advertising of any type appears in this activity. No links to product websites appear in this activity.

List of Hypertension Principal Faculty and Credentials

Carissa Baker-Smith, MD, MS, MPH,FAAP

Donald Batisky, MD, FAAP

Daniel Feig, MD, PhD, MS, FAAP

Joseph Flynn, MD, MS, FAAP

David Kershaw, MD, FCP (SA)

Kevin E. C. Meyers, MD, FAAP

Suzanne Lazorick, MD, FAAP

AAP Staff

Lori Morawski, MPH, CHES

Tamiko O’Brill, MS

Lynne Colgrove, MBA

Suzanne Kirkwood

Instructional Designer

Becky Harris, CPT, CPLP

Name of Medium or Combination of Media Used

Internet course

Method of physician participation in the learning process

TheEQIPP:Hypertension – Identification and Management course requires you to do some work online and some offline. The online work involves reviewing the content presentation, researching linked information, and participating in guided activities. The offline work includes the performance improvement activities you will do within your own practice to improve the hypertension key activities in your practice.

Please note:CME credit is only awarded to learners who enter and analyze data. Using sample data provided by EQIPP will exclude learners from receiving AMA PRA Category 1 Credit(s)™for the performance improvement activity portion of the course.

Estimated time to complete the educational activity

You may progress through the course at a pace that is comfortable for you, taking into consideration the demands of your practice. But it is important to establish a goal for completion. The amount of time you are likely to spend per clinical content area can vary depending on if you pursue additional links for more learning. You may also want to consider some elapsed time between sections to “catch your breath.”

Completion requirements for the Performance Improvement activity include:

1. Enter baseline data and analyze your results.

2. Create an improvement plan that has a minimum of 1 aim statement.

3. Document a minimum of 1 idea for change.

4. Enter data for a minimum of two follow up data set and analyze your results.

5. Submit a course evaluation.

Generally speaking, EQIPP: Hypertension - Identification and Management can be completed within 4 to 8 months, depending on the number of improvement cycles you make to reach the goals you have set for your practice.

The American Board of Pediatrics (ABP) requires completion of two follow-up data cycles to meet Maintenance of Certification (MOC) Part 4: Performance in Practice requirements. In EQIPP, a data cycle consists of Baseline data entry, an improvement plan, and follow-up data entry. You will be eligible to claim Performance Improvement (PI) Credit and notify the ABP upon completion of the second follow-up data cycles.

Instructions for Claiming Credit

You may claim 27.50 credits after completing this course. In order to complete the course, you must pass the assessments with a score of 70% or greater. Then click on the Claim Credit link in the course and follow the instructions.

Dates of Original Release and Most Recent Review or Revision

This course was launched on May 15, 2015.

Termination Date

This course will remain online until May 14, 2018. It will no longer be certified for credit after May 14, 2018.

List of Hardware/Software Requirements

Recommended browsers:

Internet Explorer 6.0 and above
Firefox 2.0 and above
Safari 1.3.2 and above
Opera 7.5 and above

Recommended browser settings:

JavaScript enabled
Cookies enabled
SSL 2.0 & SSL 3.0 enabled
Flash Player Plug-in (version 7.0 +)
Adobe Reader Plug-in (version 6.0 +)

Provider Contact information

If you have questions about this course or encounter technical problems, please contact EQIPP at eqippadmin@aap.org. Subject: EQIPP: Hypertension – Identification and Management

Privacy and Confidentiality Statement

At the American Academy of Pediatrics, we take the issue of privacy very seriously. We do not sell, distribute, barter, or transfer personally identifiable information obtained from a user to a third party. Any information collected on the Web site is only used for the purpose stated.

The AAP list is only for important Academy communications, and your e-mail address will not be sold or provided to third parties. You will not receive advertising or promotional material on this list.

The American Academy of Pediatrics may use "cookie" technology to obtain non-personal information from its online visitors. We do not extract personal information in this process nor do we provide this information to third parties. We also do not contact you based on information in your cookie file.

The American Academy of Pediatrics has taken steps to make all information received from our online visitors as secure as possible against unauthorized access and use. All information is protected by our security measures, which are periodically reviewed.